Home » Savannah Conlon

Savannah Conlon

Savannah Conlon

LinkedIn

Education:

B.S. Chemistry, Minor in Biology, University of California, Santa Cruz, 2017

From: Grass Valley, California

Joined David Lab: January 2018

Outside of lab: I enjoy long runs and skiing. You can catch me in the kitchen several nights a week because I love cooking!

Research in David Lab:

Oxidative damage to our DNA by endogenous or exogenous sources must be repaired to maintain the integrity of the genome. This type of damage is repaired via the base excision repair pathway, where glycosylases recognize and initiate repair. Specifically, I study the NEIL family of DNA glycosylases, which are required for the removal of oxidized bases from DNA. One of these enzymes, NEIL1, has been heavily characterized by our laboratory. NEIL1 has the ability to recognize and cleave a variety of oxidized lesions from differing DNA contexts. Previous work has shown that there are two wild type isoforms of this enzyme due to pre-mRNA editing by ADAR1. The two forms differ at one amino acid position, yielding either lysine or arginine at position 242 of the enzyme. Each form has different substrate preferences, some of which are shown below; therefore, it is of particular interest to investigate other differences between them. I am continuing to evaluate the intrinsic rate of glyosidic bond cleavage and the binding affinity of each form of NEIL1 on different lesions, and plan to continue this investigation with NEIL3. After seeing such a distinct difference between the two isoforms of NEIL1 in vitro, I am also interested in comparing repair initiated by each isoform in cellular assays.  I want to determine if the same trends that occur in vitro also exist in a cellular context. My hope is to further elucidate the cellular benefit of having two such isoforms.

 

Previous Research Experience:

I worked in Dr. Scott Lokey’s lab at UC Santa Cruz as an undergraduate, where I studied cyclic peptides inspired by natural products. Specifically, I worked on optimizing peptide macrocyclization by studying the effect of various reaction conditions. I aimed to help determine how to limit the unwanted oligomerization of peptides during cyclization.

RSS Science Daily News

  • 'Dancing molecules' heal cartilage damage July 26, 2024
    New therapy uses synthetic nanofibers to mimic the natural signaling of a protein that is crucial for cartilage formation and maintenance. Researchers found that intensifying the motion of molecules within the nanofibers led to more components needed for regeneration. After just four hours, the treatment activated the gene expression necessary to generate cartilage. Therapy could […]
  • New understanding of fly behavior has potential application in robotics, public safety July 26, 2024
    Scientists have identified an automatic behavior in flies that helps them assess wind conditions -- its presence and direction -- before deploying a strategy to follow a scent to its source. The fact that they can do this is surprising -- can you tell if there's a gentle breeze if you stick your head out […]
  • Lampreys possess a 'jaw-dropping' evolutionary origin July 26, 2024
    Lampreys are one of only two living jawless vertebrates Jaws are formed by a key stem cell population called the neural crest New research reveals the gene regulatory changes that may explain morphological differences between jawed and jawless vertebrates.
  • Researchers develop state-of-the-art device to make artificial intelligence more energy efficient July 26, 2024
    Engineering researchers have demonstrated a state-of-the-art hardware device that could reduce energy consumption for artificial intelligent (AI) computing applications by a factor of at least 1,000.
  • New drug shows promise in clearing HIV from brain July 25, 2024
    An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new study. By targeting infected cells in the brain, drug may clear virus from hidden areas that have been a major challenge in HIV treatment.

Contact:

Dr. Sheila S. David
ssdavid@ucdavis.edu
(530)-752-4280

Department of Chemistry
One Shields Ave.
Davis, CA 95616